GLP-1 (Glucagon-Like Peptide-1) receptor agonists are a class of medications designed to mimic the action of the natural GLP-1 hormone in the body
It's important to follow the prescribed dosage and maintain a healthy diet and exercise regimen for the best results
Specifically, this peptide seemed to suppress the growth of two types of cancer cells in experimental settings: SH-SY5Y neuroblastoma cells, which are a model for studying nerve cell behavior and pathology, and U937 histiocytic lymphoma cells, which are used to study the immune system's response to cancer
Methods In a randomised, double-blind, three-period crossover study, 31 individuals with T2DM (1864 years, body weight 80120 kg, glycosylated haemoglobin 6.08.5%) received single subcutaneous injections of IcoSema (175 U icodec, 0.5 mg semaglutide), icodec (175 U) or semaglutide (0.5 mg) with 69 weeks washout